Blood biomarkers of hepatocellular carcinoma: a critical review

Hepatocellular Carcinoma (HCC) is a malignant tumor with high morbidity and mortality worldwide, which represents a serious threat to human life, health and quality of life. Blood-based detection is essential for HCC screening, early diagnosis, prognosis evaluation, and surveillance. Current non-inv...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in cell and developmental biology 2024-11, Vol.12, p.1489836
Main Authors: Zhao, Junsheng, Hu, Zekai, Zheng, Xiaoping, Lin, Yajie, Liu, Xiao, Zhang, Junjie, Peng, Jing, Gao, Hainv
Format: Article
Language:English
Subjects:
biomarker detection technology
blood biomarkers
early diagnosis
hepatocellular carcinoma
prognosis
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hepatocellular Carcinoma (HCC) is a malignant tumor with high morbidity and mortality worldwide, which represents a serious threat to human life, health and quality of life. Blood-based detection is essential for HCC screening, early diagnosis, prognosis evaluation, and surveillance. Current non-invasive detection strategy including serum alpha-fetoprotein (AFP), ultrasound, computerized tomography, and magnetic resonance imaging. The limited specificity of an AFP and the dependence on operator experience and diagnostic personnel for ultrasound have constrained their utility in early HCC diagnosis. In recent years, with the development of various detection technologies, there has been an increasing focus on exploring blood-based detection markers for HCC. The types of markers include protein markers, DNA mutation, DNA epigenetic modification, mRNA, miRNA, and so on. However, numerous methodological and biological factors limit the clinical sensitivity and generalization performance of these new biomarkers. In this review, we describe the state-of-the-art technologies for cfDNA analysis, and discuss outstanding biological and technical challenges that, if addressed, would substantially improve HCC diagnostics and patient care.
ISSN:2296-634X
2296-634X
DOI:10.3389/fcell.2024.1489836